Abstract
Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection.
The global market for Bacteriophages (Phage) Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Bacteriophages (Phage) Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacteriophages (Phage) Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Bacteriophages (Phage) Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Bacteriophages (Phage) Products include Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma and APS Biocontrol Ltd. (APS), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacteriophages (Phage) Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bacteriophages (Phage) Products by region & country, by Type, and by Application.
The Bacteriophages (Phage) Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophages (Phage) Products.
Market Segmentation
By Company
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type:
DsDNA Type
SsDNA Type
SsRNA Type
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bacteriophages (Phage) Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bacteriophages (Phage) Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bacteriophages (Phage) Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Bacteriophages (Phage) Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Bacteriophages (Phage) Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacteriophages (Phage) Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Bacteriophages (Phage) Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Bacteriophages (Phage) Products include Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma and APS Biocontrol Ltd. (APS), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacteriophages (Phage) Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bacteriophages (Phage) Products by region & country, by Type, and by Application.
The Bacteriophages (Phage) Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophages (Phage) Products.
Market Segmentation
By Company
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type:
DsDNA Type
SsDNA Type
SsRNA Type
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bacteriophages (Phage) Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bacteriophages (Phage) Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bacteriophages (Phage) Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Bacteriophages (Phage) Products Product Introduction
1.2 Global Bacteriophages (Phage) Products Market Size Forecast
1.2.1 Global Bacteriophages (Phage) Products Sales Value (2019-2030)
1.2.2 Global Bacteriophages (Phage) Products Sales Volume (2019-2030)
1.2.3 Global Bacteriophages (Phage) Products Sales Price (2019-2030)
1.3 Bacteriophages (Phage) Products Market Trends & Drivers
1.3.1 Bacteriophages (Phage) Products Industry Trends
1.3.2 Bacteriophages (Phage) Products Market Drivers & Opportunity
1.3.3 Bacteriophages (Phage) Products Market Challenges
1.3.4 Bacteriophages (Phage) Products Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bacteriophages (Phage) Products Players Revenue Ranking (2023)
2.2 Global Bacteriophages (Phage) Products Revenue by Company (2019-2024)
2.3 Global Bacteriophages (Phage) Products Players Sales Volume Ranking (2023)
2.4 Global Bacteriophages (Phage) Products Sales Volume by Company Players (2019-2024)
2.5 Global Bacteriophages (Phage) Products Average Price by Company (2019-2024)
2.6 Key Manufacturers Bacteriophages (Phage) Products Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bacteriophages (Phage) Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bacteriophages (Phage) Products
2.9 Bacteriophages (Phage) Products Market Competitive Analysis
2.9.1 Bacteriophages (Phage) Products Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bacteriophages (Phage) Products Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophages (Phage) Products as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 DsDNA Type
3.1.2 SsDNA Type
3.1.3 SsRNA Type
3.1.4 Others
3.2 Global Bacteriophages (Phage) Products Sales Value by Type
3.2.1 Global Bacteriophages (Phage) Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bacteriophages (Phage) Products Sales Value, by Type (2019-2030)
3.2.3 Global Bacteriophages (Phage) Products Sales Value, by Type (%) (2019-2030)
3.3 Global Bacteriophages (Phage) Products Sales Volume by Type
3.3.1 Global Bacteriophages (Phage) Products Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bacteriophages (Phage) Products Sales Volume, by Type (2019-2030)
3.3.3 Global Bacteriophages (Phage) Products Sales Volume, by Type (%) (2019-2030)
3.4 Global Bacteriophages (Phage) Products Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Animal Health
4.1.2 Aquaculture
4.1.3 Agriculture
4.1.4 Food Industry
4.1.5 Others
4.2 Global Bacteriophages (Phage) Products Sales Value by Application
4.2.1 Global Bacteriophages (Phage) Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bacteriophages (Phage) Products Sales Value, by Application (2019-2030)
4.2.3 Global Bacteriophages (Phage) Products Sales Value, by Application (%) (2019-2030)
4.3 Global Bacteriophages (Phage) Products Sales Volume by Application
4.3.1 Global Bacteriophages (Phage) Products Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bacteriophages (Phage) Products Sales Volume, by Application (2019-2030)
4.3.3 Global Bacteriophages (Phage) Products Sales Volume, by Application (%) (2019-2030)
4.4 Global Bacteriophages (Phage) Products Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bacteriophages (Phage) Products Sales Value by Region
5.1.1 Global Bacteriophages (Phage) Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bacteriophages (Phage) Products Sales Value by Region (2019-2024)
5.1.3 Global Bacteriophages (Phage) Products Sales Value by Region (2025-2030)
5.1.4 Global Bacteriophages (Phage) Products Sales Value by Region (%), (2019-2030)
5.2 Global Bacteriophages (Phage) Products Sales Volume by Region
5.2.1 Global Bacteriophages (Phage) Products Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bacteriophages (Phage) Products Sales Volume by Region (2019-2024)
5.2.3 Global Bacteriophages (Phage) Products Sales Volume by Region (2025-2030)
5.2.4 Global Bacteriophages (Phage) Products Sales Volume by Region (%), (2019-2030)
5.3 Global Bacteriophages (Phage) Products Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bacteriophages (Phage) Products Sales Value, 2019-2030
5.4.2 North America Bacteriophages (Phage) Products Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bacteriophages (Phage) Products Sales Value, 2019-2030
5.5.2 Europe Bacteriophages (Phage) Products Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bacteriophages (Phage) Products Sales Value, 2019-2030
5.6.2 Asia Pacific Bacteriophages (Phage) Products Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bacteriophages (Phage) Products Sales Value, 2019-2030
5.7.2 South America Bacteriophages (Phage) Products Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bacteriophages (Phage) Products Sales Value, 2019-2030
5.8.2 Middle East & Africa Bacteriophages (Phage) Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bacteriophages (Phage) Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bacteriophages (Phage) Products Sales Value
6.2.1 Key Countries/Regions Bacteriophages (Phage) Products Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bacteriophages (Phage) Products Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bacteriophages (Phage) Products Sales Value, 2019-2030
6.3.2 United States Bacteriophages (Phage) Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bacteriophages (Phage) Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bacteriophages (Phage) Products Sales Value, 2019-2030
6.4.2 Europe Bacteriophages (Phage) Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bacteriophages (Phage) Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bacteriophages (Phage) Products Sales Value, 2019-2030
6.5.2 China Bacteriophages (Phage) Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bacteriophages (Phage) Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bacteriophages (Phage) Products Sales Value, 2019-2030
6.6.2 Japan Bacteriophages (Phage) Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bacteriophages (Phage) Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bacteriophages (Phage) Products Sales Value, 2019-2030
6.7.2 South Korea Bacteriophages (Phage) Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bacteriophages (Phage) Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bacteriophages (Phage) Products Sales Value, 2019-2030
6.8.2 Southeast Asia Bacteriophages (Phage) Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bacteriophages (Phage) Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bacteriophages (Phage) Products Sales Value, 2019-2030
6.9.2 India Bacteriophages (Phage) Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bacteriophages (Phage) Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Proteon Pharmaceuticals
7.1.1 Proteon Pharmaceuticals Company Information
7.1.2 Proteon Pharmaceuticals Introduction and Business Overview
7.1.3 Proteon Pharmaceuticals Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Proteon Pharmaceuticals Bacteriophages (Phage) Products Product Offerings
7.1.5 Proteon Pharmaceuticals Recent Development
7.2 Phagelux
7.2.1 Phagelux Company Information
7.2.2 Phagelux Introduction and Business Overview
7.2.3 Phagelux Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Phagelux Bacteriophages (Phage) Products Product Offerings
7.2.5 Phagelux Recent Development
7.3 Intralytix
7.3.1 Intralytix Company Information
7.3.2 Intralytix Introduction and Business Overview
7.3.3 Intralytix Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Intralytix Bacteriophages (Phage) Products Product Offerings
7.3.5 Intralytix Recent Development
7.4 Micreos
7.4.1 Micreos Company Information
7.4.2 Micreos Introduction and Business Overview
7.4.3 Micreos Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Micreos Bacteriophages (Phage) Products Product Offerings
7.4.5 Micreos Recent Development
7.5 Eliava BioPreparations
7.5.1 Eliava BioPreparations Company Information
7.5.2 Eliava BioPreparations Introduction and Business Overview
7.5.3 Eliava BioPreparations Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Eliava BioPreparations Bacteriophages (Phage) Products Product Offerings
7.5.5 Eliava BioPreparations Recent Development
7.6 Locus Biosciences,Inc
7.6.1 Locus Biosciences,Inc Company Information
7.6.2 Locus Biosciences,Inc Introduction and Business Overview
7.6.3 Locus Biosciences,Inc Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Locus Biosciences,Inc Bacteriophages (Phage) Products Product Offerings
7.6.5 Locus Biosciences,Inc Recent Development
7.7 Pharmex Group,LLC
7.7.1 Pharmex Group,LLC Company Information
7.7.2 Pharmex Group,LLC Introduction and Business Overview
7.7.3 Pharmex Group,LLC Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pharmex Group,LLC Bacteriophages (Phage) Products Product Offerings
7.7.5 Pharmex Group,LLC Recent Development
7.8 Pherecydes Pharma
7.8.1 Pherecydes Pharma Company Information
7.8.2 Pherecydes Pharma Introduction and Business Overview
7.8.3 Pherecydes Pharma Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pherecydes Pharma Bacteriophages (Phage) Products Product Offerings
7.8.5 Pherecydes Pharma Recent Development
7.9 APS Biocontrol Ltd. (APS)
7.9.1 APS Biocontrol Ltd. (APS) Company Information
7.9.2 APS Biocontrol Ltd. (APS) Introduction and Business Overview
7.9.3 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.9.4 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Product Offerings
7.9.5 APS Biocontrol Ltd. (APS) Recent Development
7.10 Qingdao Phagepharm Bio-tech
7.10.1 Qingdao Phagepharm Bio-tech Company Information
7.10.2 Qingdao Phagepharm Bio-tech Introduction and Business Overview
7.10.3 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Product Offerings
7.10.5 Qingdao Phagepharm Bio-tech Recent Development
7.11 Fixed-Phage Limited
7.11.1 Fixed-Phage Limited Company Information
7.11.2 Fixed-Phage Limited Introduction and Business Overview
7.11.3 Fixed-Phage Limited Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Fixed-Phage Limited Bacteriophages (Phage) Products Product Offerings
7.11.5 Fixed-Phage Limited Recent Development
7.12 Zeptometrix
7.12.1 Zeptometrix Company Information
7.12.2 Zeptometrix Introduction and Business Overview
7.12.3 Zeptometrix Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Zeptometrix Bacteriophages (Phage) Products Product Offerings
7.12.5 Zeptometrix Recent Development
7.13 Phage International, Inc.
7.13.1 Phage International, Inc. Company Information
7.13.2 Phage International, Inc. Introduction and Business Overview
7.13.3 Phage International, Inc. Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Phage International, Inc. Bacteriophages (Phage) Products Product Offerings
7.13.5 Phage International, Inc. Recent Development
7.14 MicroMir
7.14.1 MicroMir Company Information
7.14.2 MicroMir Introduction and Business Overview
7.14.3 MicroMir Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.14.4 MicroMir Bacteriophages (Phage) Products Product Offerings
7.14.5 MicroMir Recent Development
7.15 iNtODEWORLD, Inc.
7.15.1 iNtODEWORLD, Inc. Company Information
7.15.2 iNtODEWORLD, Inc. Introduction and Business Overview
7.15.3 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.15.4 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Product Offerings
7.15.5 iNtODEWORLD, Inc. Recent Development
7.16 NEXTBIOTICS
7.16.1 NEXTBIOTICS Company Information
7.16.2 NEXTBIOTICS Introduction and Business Overview
7.16.3 NEXTBIOTICS Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.16.4 NEXTBIOTICS Bacteriophages (Phage) Products Product Offerings
7.16.5 NEXTBIOTICS Recent Development
7.17 Armata Pharmaceuticals, Inc.
7.17.1 Armata Pharmaceuticals, Inc. Company Information
7.17.2 Armata Pharmaceuticals, Inc. Introduction and Business Overview
7.17.3 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Product Offerings
7.17.5 Armata Pharmaceuticals, Inc. Recent Development
7.18 Innophage
7.18.1 Innophage Company Information
7.18.2 Innophage Introduction and Business Overview
7.18.3 Innophage Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Innophage Bacteriophages (Phage) Products Product Offerings
7.18.5 Innophage Recent Development
7.19 Adaptive Phage Therapeutics
7.19.1 Adaptive Phage Therapeutics Company Information
7.19.2 Adaptive Phage Therapeutics Introduction and Business Overview
7.19.3 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Product Offerings
7.19.5 Adaptive Phage Therapeutics Recent Development
7.20 TechnoPhage
7.20.1 TechnoPhage Company Information
7.20.2 TechnoPhage Introduction and Business Overview
7.20.3 TechnoPhage Bacteriophages (Phage) Products Sales, Revenue and Gross Margin (2019-2024)
7.20.4 TechnoPhage Bacteriophages (Phage) Products Product Offerings
7.20.5 TechnoPhage Recent Development
8 Industry Chain Analysis
8.1 Bacteriophages (Phage) Products Industrial Chain
8.2 Bacteriophages (Phage) Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bacteriophages (Phage) Products Sales Model
8.5.2 Sales Channel
8.5.3 Bacteriophages (Phage) Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer